<DOC>
	<DOCNO>NCT01479114</DOCNO>
	<brief_summary>The investigator aim evaluate effect G-CSF administration septic neonate neutrophil production CD11b expression .</brief_summary>
	<brief_title>Effect Recombinant Human Granulocyte Colony- Stimulating Factor CD11b Septic Neonates</brief_title>
	<detailed_description>Neonates susceptible septicemia secondary quantitative qualitative neutrophilic defect . Granulocyte-colony stimulating factor ( G-CSF ) stimulate myeloid progenitor cell proliferation induces selective neutrophil function .</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>newborn infant postnatal age &lt; 28 day , minimum gestational age 28 week require intensive care clinical sign consistent diagnosis neonatal sepsis , without neutropenia neonate congenital malformation , major chromosomal abnormality , prior use cytokine intravenous immunoglobulin , decrease hemoglobin and/or hematocrit level necessitate transfusion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>